Cytokinetics, Incorporated is a company in the U.S. stock market and it is a holding in 56 U.S.-traded ETFs. CYTK has around 10.3M shares in the U.S. ETF market. The largest ETF holder of CYTK is the iShares Core S&P Small-Cap ETF (IJR), with approximately 3.67M shares. Investors may also find of interest that the ETF with the largest allocation to CYTK stock is Invesco S&P SmallCap Health Care ETF (PSCH), with a portfolio weight of 1.64%. On average, U.S. ETFs allocate 0.20% of CYTK to their portfolios.
Additionally, CYTK is a favorite stock for Vanilla and Momentum ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CYTK as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.93%.